These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32334759)

  • 1. Naloxone counseling: Confidence and attitudes of student pharmacists after a volunteer syringe exchange experience.
    Kuryluk V; McAuley J; Maguire M
    Curr Pharm Teach Learn; 2020 Apr; 12(4):429-433. PubMed ID: 32334759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Student pharmacist perceptions of participation in hands-on naloxone counseling.
    Hines J; Deja E; Black EP
    Curr Pharm Teach Learn; 2018 Jun; 10(6):712-716. PubMed ID: 30025770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and assessment of a naloxone-training program for first-year student pharmacists.
    Schartel A; Lardieri A; Mattingly A; Feemster AA
    Curr Pharm Teach Learn; 2018 Jun; 10(6):717-722. PubMed ID: 30025771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of student pharmacists' knowledge and skills regarding overdose management with naloxone.
    Jacobson AN; Bratberg JP; Monk M; Ferrentino J
    Subst Abus; 2018; 39(2):193-198. PubMed ID: 29432081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operation Naloxone: Overdose prevention service learning for student pharmacists.
    Hill LG; Sanchez JP; Laguado SA; Lawson KA
    Curr Pharm Teach Learn; 2018 Oct; 10(10):1348-1353. PubMed ID: 30527364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Laboratory Session to Prepare Pharmacy Students to Manage the Opioid Crisis Situation.
    Donohoe KL; Raghavan A; Tran TT; Alotaibi FM; Powers KE; Frankart LM
    Am J Pharm Educ; 2019 Sep; 83(7):6988. PubMed ID: 31619820
    [No Abstract]   [Full Text] [Related]  

  • 7. A naloxone and harm reduction educational program across four years of a doctor of pharmacy program.
    Maguire MA; Pavlakos RN; Mehta BH; Schmuhl KK; Beatty SJ
    Curr Pharm Teach Learn; 2018; 10(1):72-77. PubMed ID: 29248078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparing student pharmacists to identify opioid misuse, prevent overdose and prescribe naloxone.
    Skoy E; Eukel H; Frenzel J; Werremeyer A
    Curr Pharm Teach Learn; 2019 May; 11(5):522-527. PubMed ID: 31171255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid overdose response training in pharmacy education: An analysis of students' perception of naloxone use for opioid overdose prevention.
    Bachyrycz A; Takeda MY; Wittstrom K; Bleske B
    Curr Pharm Teach Learn; 2019 Feb; 11(2):166-171. PubMed ID: 30733013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implementation of a naloxone rescue program in university students.
    Panther SG; Bray BS; White JR
    J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Theory of Planned Behavior to determine pharmacy students' intention to participate in hormonal contraception counseling services.
    Hohmann N; Kavookjian J
    Curr Pharm Teach Learn; 2018 Nov; 10(11):1488-1495. PubMed ID: 30514539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of data.
    Murnane KS; Augustine JM; Marshall LL
    Curr Pharm Teach Learn; 2022 Oct; 14(10):1222-1228. PubMed ID: 36283793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study.
    Olsen A; Lawton B; Dwyer R; Taing MW; Chun KLJ; Hollingworth S; Nielsen S
    Int J Drug Policy; 2019 Jul; 69():46-52. PubMed ID: 31078908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
    Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and delivery of a pharmacist training program to increase naloxone access in Kentucky.
    Palmer E; Hart S; Freeman PR
    J Am Pharm Assoc (2003); 2017; 57(2S):S118-S122. PubMed ID: 28161300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists.
    Thompson EL; Rao PSS; Hayes C; Purtill C
    J Pharm Pract; 2019 Aug; 32(4):412-421. PubMed ID: 29478362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.
    Burstein D; Baird J; Bratberg J; Donovan E; Soipe A; Tapper A; Case P; Walley AY; Green TC
    J Am Pharm Assoc (2003); 2020; 60(2):304-310. PubMed ID: 31870862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency department physicians' and pharmacists' perspectives on take-home naloxone.
    Holland TJ; Penm J; Dinh M; Aran S; Chaar B
    Drug Alcohol Rev; 2019 Feb; 38(2):169-176. PubMed ID: 30697852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.